The estimated Net Worth of Michael Lane is at least 11.9 百万$ dollars as of 14 February 2024. Mr. Lane owns over 939 units of Idexx Laboratories stock worth over 3,297,489$ and over the last 6 years he sold IDXX stock worth over 7,113,410$. In addition, he makes 1,473,880$ as Executive Vice President、 General Manager、 Reference Laboratories and Information Technology at Idexx Laboratories.
Michael has made over 15 trades of the Idexx Laboratories stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 939 units of IDXX stock worth 460,354$ on 14 February 2024.
The largest trade he's ever made was selling 17,961 units of Idexx Laboratories stock on 5 August 2019 worth over 4,743,500$. On average, Michael trades about 3,965 units every 125 days since 2018. As of 14 February 2024 he still owns at least 6,726 units of Idexx Laboratories stock.
You can see the complete history of Mr. Lane stock trades at the bottom of the page.
Michael J. Lane serves as Executive Vice President, General Manager, Reference Laboratories and Information Technology of the Company. Mr. Lane has been a Corporate Vice President since July 2015 and General Manager of IDEXX’s Global Reference Laboratories business since November 2016. Prior to becoming the General Manager of our Global Reference Laboratories business, he served as the General Manager of the Company’s U.S. Reference Laboratories from June 2014, and as Vice President from 2012, until July 2015. In addition to his responsibilities for the Reference Laboratories business, from July 2015 through December 2016, Mr. Lane provided strategic direction for the Company’s SNAP® Point-of-Care testing. Mr. Lane joined IDEXX in 1997, supporting strategic planning and business development for diagnostic laboratory services as IDEXX entered the global reference laboratory market segment. In 1999, he joined the IDEXX VetLab organization, where he held various leadership positions with responsibilities in commercial marketing, product management, and new product development, and served from 2012 to May 2014 as Vice President and General Manager. Mr. Lane holds a bachelor’s degree in international politics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth College.
As the Executive Vice President、 General Manager、 Reference Laboratories and Information Technology of Idexx Laboratories, the total compensation of Michael Lane at Idexx Laboratories is 1,473,880$. There are 6 executives at Idexx Laboratories getting paid more, with Jonathan Ayers having the highest compensation of 8,309,800$.
Michael Lane is 52, he's been the Executive Vice President、 General Manager、 Reference Laboratories and Information Technology of Idexx Laboratories since 2020. There are 22 older and 2 younger executives at Idexx Laboratories. The oldest executive at Idexx Laboratories, Inc. is M. Anne Szostak, 69, who is the Independent Director.
Michael's mailing address filed with the SEC is ONE IDEXX DRIVE, , WESTBROOK, ME, 04092.
Over the last 21 years, insiders at Idexx Laboratories have traded over 238,711,289$ worth of Idexx Laboratories stock and bought 24,695 units worth 3,109,424$ . The most active insiders traders include Stuart Essig、Johnny D Powers、Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of 4,641,291$. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth 234,685$.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
Idexx Laboratories executives and other stock owners filed with the SEC include: